Dean Health Foundation of Madison Wisconsin is participating in an Alzheimer's study. The study is being conducted in approximately 70 sites throughout North America and Europe. Study is number 554.
A prodromal event is an early sign or warning of a developing disorder. The earliest signs of Alzheimer's disease are memory loss with spinal fluid abnormalities. Spinal fluid abnormalities provide the researchers with lead biological indicators of the disease process. Focus on the beginning stages of Alzheimer's disease is to produce effective treatments for individual's newly diagnosed with the disease.
Phase II of study 554 is to assess the patients response to an investigational medication BMS 708163 Bristol Meyers Squibb. Volunteers will receive study related medical care, study medication, laboratory testing, and cognitive testing. Medical insurance is not necessary to participate in the study. Reimbursement for travel may be available. Home Care Path www.homecarepath.com staff accompany seniors to provider visits. Study participants must have a consistent person to attend the visits.
Contact JoAnn with Dean Foundation 608-827-2333 Madison Wisconsin.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment